Northern Nanotechnologies MSDS Cd Te rev 1.2 Eng Page 4
Boiling Point: 100 șC (~ 212 F)
Freezing Point: 0 șC (~ 32 F)
Vapour pressure: N/A
Specific gravity (water = 1): ~ 1.0
pH: ~ 7-8
Section 10 Reactivity
Chemical stability: Stable if used according to specifications.
Conditions to avoid: None known.
Incompatible Materials: None known.
Hazardous decomposition products: No hazardous decomposition products
have been identified.
Section 11 Toxicological information:
Cadmium compounds:
Short Term Exposure:
Inhalation: Dust may cause irritation of the nose and throat. Non-fatal lung
inflammation has been reported from concentrations of 0.5 2.5 mg/m3. In 4
10 hours after exposure severe chest pain, with persistent cough and difficult
breathing, headache, chills, muscle aches, nausea, vomiting, diarrhea. Fluid in
the lungs (pulmonary edema) and dark-purple coloration of the skin may occur.
Pulmonary edema is a medical emergency that can be delayed for several hours.
This can cause death. Breathing becomes more difficult and is accompanied by
wheezing or coughing of blood. Other symptoms which may occur 12 36 hours
after exposure in addition to those above include dizziness, irritability,
gastrointestinal disturbances, shortness of breath, fever, profuse sweating,
exhaustion and inflammation of the lungs. Death may result within 7 10 days
after exposure. The average concentrations of fume responsible for fatalities
have been 40 50 mg/m3 for 1 hour, 9 mg/m3 for 5 hours, or 5 mg/m3 for 8
hours.
Skin: Absorption is negligible.
Eyes: Cadmium compound dust may cause irritation.
Ingestion: A dose of 15 30 mg (1/1000 oz) of metal or soluble compounds may
cause increased salivation, choking, vomiting, abdominal pain, anemia, kidney
malfunction, diarrhea, and persistent desire to empty the bladder. Symptoms
Northern Nanotechnologies Inc., 700 Bay St., Suite 1100, Toronto, ON M5G 1Z6 Tel (416) 260-8889 Fax (416) 260-8839
